Most juvenile idiopathic arthritis (JIA) patients need to attend adult rheumatology centres to
continue the clinical management of their disease and to receive adequate long-term …

Objective. To evaluate safety and efficacy of adalimumab (ADA) and infliximab (IFX) for the
treatment of juvenile idiopathic arthritis-related anterior uveitis (JIA-AU). Methods. Starting …

The purpose of this study is to review the current literature on the use of hyaluronic acid (HA)
specifically applied to the treatment of osteoarthritis (OA) secondary to primary inflammatory …

Purpose: To evaluate the long-term efficacy of golimumab in patients with severe recalcitrant
uveitis who had inadequate response to previous biologics. Methods: Retrospective study (…

Background/aims To evaluate retrospectively the long-term efficacy of rituximab in patients
with severe juvenile idiopathic arthritis (JIA)-associated uveitis. Methods Eight patients (15 …

To present our preliminary experience with JAK inhibitors in treating patients affected by
juvenile idiopathic arthritis (JIA) and associated uveitis. Case series. Four consecutive patients …

Background: Interleukin (IL)-1 plays a crucial role in the pathogenesis of Adult onset Still’s
disease (AOSD). Objectives: To evaluate the efficacy and safety of anakinra (ANA) and …

Objective. Anti-TNF-α agents have significantly changed the management of juvenile idiopathic
arthritis (JIA). We evaluated the safety and efficacy of adalimumab (ADA) and infliximab (…

Objective. With the increasing use of etanercept for juvenile idiopathic arthritis (JIA) new
possible adverse events are reported including new autoimmune diseases. Our purpose was to …

Background Little evidence-based information is available to guide the treatment of
oligoarticular juvenile idiopathic arthritis. We aimed to investigate whether oral methotrexate …